S-1226
id:
s-1226-296-17830403
title:
S-1226
text:
S-1226, or S1226, is a mixture of carbon dioxide-enriched air and nebulized perflubron being developed as a novel bronchodilator for use in respiratory diseases such as asthma, cystic fibrosis, and COVID-19 by SolAeroMed. Unlike typical bronchodilators such as β2-adrenergic agonists and antimuscarinics, S-1226 does not act on receptors in the airways. Instead, it combines the bronchodilator activity of gaseous carbon dioxide with the mucolytic properties of the synthetic surfactant perflubron to
brand slug:
wiki
category slug:
encyclopedia
description:
A novel bronchodilator formulation for the treatment of respiratory diseases.
original url:
https://en.wikipedia.org/wiki/S-1226
date created:
date modified:
2024-01-01T19:52:49Z
main entity:
{"identifier":"Q124048107","url":"https://www.wikidata.org/entity/Q124048107"}
image:
fields total:
13
integrity:
14